4th Quarter - Report
THE MCMANUS GROUP for DENDREON PHARMACEUTICALS LLC
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Access to Part B drugs. Most Favored Nation (MFN) Model, (CMS-5528-IFC). Changes to the ASP add-on payment in S. 2543 The Prescription Drug Pricing Reduction Act of 2019 and H.R. 19/S.3129 The Lower Cost, More Cures Act of 2019.
Foreign entity interest: Dendreon is a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
| ALANNA TEMME | LD, Rep. Jon Porter |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.